Endoscopy 2021; 53(S 01): S134
DOI: 10.1055/s-0041-1724614
Abstracts | ESGE Days
ESGE Days 2021 Digital poster exhibition

Impact Of Taking Biopsies In Macroscopically Normal Endoscopies On The Nhs - Is There Inter-Operator Variability And Need For Stringent Guidelines And Training?

N Cianci
1   University of Nottingham, Nottingham, United Kingdom
,
B Varghese
2   Queen’s Medical Centre, Nottingham, United Kingdom
,
A Sreedharan
3   United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom
,
S Saha
3   United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom
,
A Khanna
4   Kings College Hospital, Institute of Liver Science, London, United Kingdom
5   Queen Elizabeth Hospital, Liver Unit, Birmingham, United Kingdom
6   Newcastle University, Institute of Cellular Medicine, Newcastle, United Kingdom
,
A Mandal
3   United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom
› Author Affiliations
 
 

    Aims Numerous studies have questioned the value of taking biopsies in macroscopically-normal mucosa. Inappropriate biopsies increase financial and time pressures on the increasingly-strained endoscopy, pathology and NHS services. We hypothesized that non-physician endoscopists have greater uptake on performing biopsies in macroscopically normal endoscopies.

    Methods We did a retrospective study of diagnostic gastroscopies and colonoscopies performed across 3 district-general hospitals (January-November 2018) in United Lincolnshire Hospitals NHS Trust. Endoscopic reports were examined for age, sex, indication, endoscopic diagnosis, biopsies taken (yes/no), and operator (gastroenterologist/surgeon/nurse endoscopist {NE}). We classified ‘biopsy not indicated’ when mucosa was described as ‘normal’ for indications of anaemia, rectal bleeding, weight-loss in colonoscopies, and dyspepsia, vomiting and abdominal pain in gastroscopies.

    Results A total of 326 gastroscopies and 355 colonoscopies were included. 170 procedures fulfilled the ‘biopsy not indicated’ classification, of which 59 % had multiple biopsies taken. Biopsy rates among gastroenterologists, surgeons, and NEs in ‘biopsy not indicated’ were 53 % (39/73), 60 % (42/70) and 70 % (19/27) respectively. Using Chi-square, there was no statistically significant difference between various groups: surgeons and NEs (p= 0.34), surgeons and gastroenterologists (p= 0.42), and gastroenterologists and NEs (p= 0.12). This rejects our hypothesis.

    Conclusions Our study showed that a significant number of biopsies are performed without good indication, with no significant inter-operator variability. Both British Society of Gastroenterology and National Institute for Health and Care Excellence have published guidance on when biopsy is indicated, but there are few high-level recommendations on when not to biopsy. Findings from our study mandate development of such guidance, followed by training of all endoscopists and UK-wide audit of local practice to ensure compliance with guidelines. The implementation of such strategies has been proven effective at a local level, and if adopted nationally can significantly optimise financial burden of endoscopy services on the NHS.

    Citation Cianci N, Varghese B, Sreedharan A et al. eP116 IMPACT OF TAKING BIOPSIES IN MACROSCOPICALLY NORMAL ENDOSCOPIES ON THE NHS - IS THERE INTER-OPERATOR VARIABILITY AND NEED FOR STRINGENT GUIDELINES AND TRAINING?. Endoscopy 2021; 53: S134.


    #

    Publication History

    Article published online:
    19 March 2021

    © 2021. European Society of Gastrointestinal Endoscopy. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany